Pancreatic tumors refer to abnormal growths in the pancreas, a gland located behind the stomach that plays a key role in digestion and blood sugar regulation. These tumors can be benign (non-cancerous) or malignant (cancerous), with the latter being more common and typically more dangerous. Pancreatic tumors can arise from different types of cells in the pancreas, including the exocrine cells that produce digestive enzymes (exocrine tumors) and the hormone-producing cells (endocrine tumors). The most common type of pancreatic cancer is adenocarcinoma, which originates in the exocrine cells. Risk factors for pancreatic tumors include smoking, obesity, chronic pancreatitis, family history of pancreatic cancer, and certain genetic conditions. Symptoms of pancreatic tumors can include abdominal pain, weight loss, jaundice, digestive issues, and changes in blood sugar levels. Diagnosis of pancreatic tumors often involves imaging tests like CT scans and MRIs, as well as biopsy to confirm the presence of cancer cells. Treatment options for pancreatic tumors may include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy, depending on the type and stage of the tumor. Prognosis for pancreatic cancer is generally poor, as it is often diagnosed at an advanced stage when treatment options are limited. Early detection and treatment can significantly improve outcomes for patients with pancreatic tumors.